Not applicableUnknownNCT03763214What this trial is testingPTFE Stents for Treatment of Malignant Biliary StricturesWho this might be right forBile Duct StrictureBile Duct CancerPancreas Cancer Johannes Vermehren 64
Not applicableUnknownNCT04337333What this trial is testingTwo-in-one Covered and Uncovered Metal StentWho this might be right forExtrahepatic Bile Duct CancerPancreatic CancerLymph Node Metastases+1 more Ajou University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT02042443What this trial is testingTrametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by SurgeryWho this might be right forAdult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more National Cancer Institute (NCI) 53
Not applicableEnded earlyNCT04561453What this trial is testingFeasibility Study of Multi-Platform Profiling of Resected Biliary Tract CancerWho this might be right forBiliary Tract CancerCholangiocarcinomaGallbladder Cancer+5 more University of Washington 14
Not applicableLooking for participantsNCT06801899What this trial is testingToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary CancerWho this might be right forPancreatic Cancer Insel Gruppe AG, University Hospital Bern 170
Not applicableStudy completedNCT05478889What this trial is testingMinimally Invasive Pancreatoduodenectomy for Distal CholangiocarcinomaWho this might be right forDistal Cholangiocarcinoma Fondazione Poliambulanza Istituto Ospedaliero 478
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Post-approval studies (Phase 4)Study completedNCT00280709What this trial is testingBiliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary ObstructionWho this might be right forBile Duct ObstructionPancreatic CancerGallbladder Cancer+1 more University Hospital, Linkoeping 400
Not applicableActive Not RecruitingNCT06453590What this trial is testingTreatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal StentsWho this might be right forPancreatic Cancer Non-resectableBile Duct CancerPapillary Carcinoma+1 more Region Stockholm 450
Testing effectiveness (Phase 2)Ended earlyNCT05251233What this trial is testingRole of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyWho this might be right forPancreatic CancerPancreas CancerAmpullary Cancer+4 more Washington University School of Medicine 56
Not applicableStudy completedNCT01514214What this trial is testingWinged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct ObstructionWho this might be right forMalignant Tumor of Extrahepatic Bile Duct University of British Columbia 58
Testing effectiveness (Phase 2)Study completedNCT04072445What this trial is testingTrifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more Mayo Clinic 28
Not applicableStudy completedNCT04596865What this trial is testingRecurrence After Whipple's (RAW) StudyWho this might be right forPancreatic CancerAmpullary CancerBile Duct Cancer+11 more University Hospital Plymouth NHS Trust 1,484
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableUnknownNCT03821025What this trial is testingSelf-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary ObstructionWho this might be right forBile Duct Obstruction, ExtrahepaticCancer of the PancreasCancer of the Bile Duct+1 more University of Cape Town 150
Large-scale testing (Phase 3)Study completedNCT03768414What this trial is testingGemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersWho this might be right forStage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8+14 more SWOG Cancer Research Network 452
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01425879What this trial is testingMK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryWho this might be right forAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287What this trial is testingTesting A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract CancerWho this might be right forMetastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more National Cancer Institute (NCI) 57